xiliotx.com (XLO) - Yalpi foyda normasi

xiliotx.com (XLO) kompaniyasining rasmiy ramzlari

Sog'liqni saqlash giganti bilan hamkorlik hozirgi vaqtda Xilio Therapeutics, Inc. (XLO) ning pul oqimlarini sezilarli darajada yaxshilamoqda. Rejalashtirilgan yalpi foyda operatsion samaradorlik tendentsiyasini aniq namoyish etmoqda, bunda joriy ko'rsatkich 97.60 ni tashkil etgan. Brendning immuno-onkologiya sohasidagi yuqori ilmiy nufuzi dori vositalarining maqsadli faollashtirilishi bilan mustahkamlanmoqda. Sinovlarning ishonchliligi esa eksperimental dozalarni tashish jarayonidagi qimmatbaho sovuq zanjir orqali ta'minlanadi.

Xilio (XLO) - Yalpi marja 04.07.2022dan 20.11.2026gacha

Xilio (XLO) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Fundamental baholash:Xilio Therapeutics, Inc.
Xilio Therapeutics Inc brend mahsuloti

Yalpi marja bevosita ishlab chiqarish xarajatlari chegirib tashlanganidan keyin qolgan daromad qismini belgilaydi va bu asosiy foyda generatsiyasi samaradorligini baholash imkonini beradi. Yalpi foyda marjasini tahlil qilish orqali investor xomashyo va resurs xarajatlarining rentabellikka ta'sirini ko'rishi mumkin, bu esa Xilio Therapeutics, Inc. (XLO) uchun onkologiya laboratoriyasidan foydalanishni optimallashtirishga va shartnomaviy ishlab chiqarish maydonchalari samaradorligiga bevosita bog'liqdir.

Asosiy raqobatchilar

Yalpi foyda marjasi BeiGene Ltd. (ONC)|Yalpi foyda bo'yicha rentabellik HALO|Yalpi rentabellik RVMD|Yalpi foyda bo'yicha rentabellik AAPG (Ascentage)|Yalpi foyda bo'yicha rentabellik cgoncology.com CGON|UroGen Pharma - Yalpi foyda bo'yicha rentabellik|Yalpi foyda normasi BCAX|PSNL - Yalpi rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi Erasca Oncology ERAS|delcath.com (DCTH) - Yalpi rentabellik|Y-mAbs Therapeutics - Yalpi foyda normasi|AURA (Aura Biosciences Inc) - Yalpi marja|Yalpi foyda marjasi candeltx.com CADL|Yalpi marja ARAY|SLS (SELLAS Life Sciences Group, Inc.) - Yalpi foyda normasi|Yalpi rentabellik Actuate Therapeutics, Inc. ACTU|citiusonc.com - Yalpi rentabellik|TuHURA Biosciences Inc. - Yalpi marja|TARA - Yalpi marja|FATE (Fate Therapeutics) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda bo'yicha rentabellik Aadi Bioscience, Inc.|Yalpi foyda bo'yicha rentabellik TCRX|Yalpi rentabellik CSBR|Yalpi marja XBIT|Yalpi foyda bo'yicha sotuv rentabelligi CEL-SCI Corp.|Yalpi rentabellik ostherapies.com OSTX|RADX: Sotuvning yalpi rentabelligi|ARTV: Yalpi foyda bo'yicha rentabellik|ANL (Adlai Nortye) - Sotuvning yalpi rentabelligi|Veru (VERU) - Yalpi rentabellik|Yalpi foyda bo'yicha rentabellik Tempest Therapeutics Inc|Yalpi rentabellik Renovaro|Yalpi marja muraloncology.com|Yalpi marja KAPA|Yalpi foyda bo'yicha sotuv rentabelligi OnKure Therapeutics, Inc.|Yalpi marja GDTC (w2.cytomed.sg)|CRIS - Yalpi foyda bo'yicha rentabellik|Apollomics - Yalpi marja|Tharimmune Corp (THAR) - Yalpi foyda bo'yicha rentabellik|ADVB: Yalpi marja|Yalpi foyda bo'yicha rentabellik Genprex|CLDI (Calidi Biotherapeutics, Inc.) - Yalpi marja|Sotuvning yalpi rentabelligi SBFM (Sunshine Biopharma)|Yalpi rentabellik Xenetic Bio (XBIO)|Yalpi rentabellik SLRX (Salarius Pharma)|Kitov Pharma - Yalpi foyda bo'yicha rentabellik|American Oncology Network (AONC) - Yalpi foyda marjasi|BeiGene - Yalpi marja|Checkpoint Therapeutics, Inc. (CKPT) - Yalpi foyda bo'yicha rentabellik|ELEV (Elevation Oncology, Inc.) - Yalpi foyda bo'yicha rentabellik|iCAD Inc. - Yalpi foyda normasi|Yalpi foyda bo'yicha rentabellik IKNA|Yalpi marja notablelabs.com|Yalpi foyda bo'yicha rentabellik VIRX (Viracta Therapeutics Inc.)|MOR - Yalpi foyda marjasi|Yalpi rentabellik NAYA Biosciences NAYA|AAPGV - Yalpi foyda bo'yicha rentabellik